CoChat
Sign Up
Cited by 107

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

RETRACTED: Leptin attenuates BACE1 expression and amyloid-β genesis via the activation of SIRT1 signaling pathway

Marwarha, Gurdeep, Raza, Shaneabbas, Meiers, Craig, Ghribi, Othman·2014·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
DOI 10.1016/j.bbadis.2014.05.015PMC PMC4125440
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbadis.2014.05.015This paper is marked retracted.

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • There is an inverse relationship between BACE1 and leptin signaling: BACE1 expression is suppressed by leptin signaling, whereas BACE1 levels are increased by both obesity and T2D.

    “There is evidence of an inverse relationship between BACE1 and leptin signaling. BACE1 expression is suppressed by leptin signaling, whereas BACE1 levels are increased by both obesity and T2D.”

    From BACE1: More than just a β‐secretase (2022) · cites this paper as [114]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 63

  1. Tanzi, 2005, Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective, Cell, 120, 545, 10.1016/j.cell.2005.02.008 · DOI · Paper page
  2. Forman, 2004, Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs, Nat. Med., 10, 1055, 10.1038/nm1113 · DOI · Paper page
  3. Anderson, 2003, Yeast life-span extension by calorie restriction is independent of NAD fluctuation, Science, 302, 2124, 10.1126/science.1088697 · DOI
  4. Cohen, 2004, Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase, Science, 305, 390, 10.1126/science.1099196 · DOI · Paper page
  5. Luo, 2001, Negative control of p53 by Sir2alpha promotes cell survival under stress, Cell, 107, 137, 10.1016/S0092-8674(01)00524-4 · DOI · Paper page
  6. Picard, 2004, Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma, Nature, 429, 771, 10.1038/nature02583 · DOI
  7. Li, 2007, SIRT1 deacetylates and positively regulates the nuclear receptor LXR, Mol. Cell, 28, 91, 10.1016/j.molcel.2007.07.032 · DOI
  8. Kaltschmidt, 1997, Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease, Proc. Natl. Acad. Sci. U. S. A., 94, 2642, 10.1073/pnas.94.6.2642 · DOI
  9. Kaltschmidt, 1999, Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis, Proc. Natl. Acad. Sci. U. S. A., 96, 9409, 10.1073/pnas.96.16.9409 · DOI
  10. Camandola, 2000, The lipid peroxidation product 4-hydroxy-2,3-nonenal inhibits constitutive and inducible activity of nuclear factor kappa B in neurons, Brain Res. Mol. Brain Res., 85, 53, 10.1016/S0169-328X(00)00234-5 · DOI
  11. Tamagno, 2002, Oxidative stress increases expression and activity of BACE in NT2 neurons, Neurobiol. Dis., 10, 279, 10.1006/nbdi.2002.0515 · DOI · Paper page
  12. Tamagno, 2005, Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways, J. Neurochem., 92, 628, 10.1111/j.1471-4159.2004.02895.x · DOI · Paper page
  13. Bourne, 2007, Differential regulation of BACE1 promoter activity by nuclear factor-kappaB in neurons and glia upon exposure to beta-amyloid peptides, J. Neurosci. Res., 85, 1194, 10.1002/jnr.21252 · DOI
  14. Buggia-Prevot, 2008, NFkappaB-dependent control of BACE1 promoter transactivation by Abeta42, J. Biol. Chem., 283, 10037, 10.1074/jbc.M706579200 · DOI
  15. Guglielmotto, 2012, AGEs/RAGE complex upregulates BACE1 via NF-kappaB pathway activation, Neurobiol. Aging, 33, 196.e13-27, 10.1016/j.neurobiolaging.2010.05.026 · DOI
  16. Donmez, 2010, SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10, Cell, 142, 320, 10.1016/j.cell.2010.06.020 · DOI
  17. Qian, 1998, Leptin regulation of peroxisome proliferator-activated receptor-gamma, tumor necrosis factor, and uncoupling protein-2 expression in adipose tissues, Biochem. Biophys. Res. Commun., 246, 660, 10.1006/bbrc.1998.8680 · DOI
  18. Greco, 2010, Chronic leptin supplementation ameliorates pathology and improves cognitive performance in a transgenic mouse model of Alzheimer's disease, J. Alzheimers Dis., 19, 1155, 10.3233/JAD-2010-1308 · DOI
  19. Tezapsidis, 2009, Leptin: a novel therapeutic strategy for Alzheimer's disease, J. Alzheimers Dis., 16, 731, 10.3233/JAD-2009-1021 · DOI
  20. Marwarha, 2010, Leptin reduces the accumulation of Abeta and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slices, J. Alzheimers Dis., 19, 1007, 10.3233/JAD-2010-1298 · DOI
  21. Marwarha, 2011, Molecular interplay between leptin, insulin-like growth factor-1, and beta-amyloid in organotypic slices from rabbit hippocampus, Mol. Neurodegener., 6, 41, 10.1186/1750-1326-6-41 · DOI
  22. Marwarha, 2012, Leptin signaling and Alzheimer's disease, Am. J. Neurodegener. Dis., 1, 245
  23. Marwarha, 2012, Cellular model of Alzheimer's disease—relevance to therapeutic testing, Exp. Neurol., 233, 733, 10.1016/j.expneurol.2011.11.011 · DOI
  24. Lieb, 2009, Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging, JAMA, 302, 2565, 10.1001/jama.2009.1836 · DOI · Paper page
  25. Power, 2001, Circulating leptin levels and weight loss in Alzheimer's disease patients, Dement. Geriatr. Cogn. Disord., 12, 167, 10.1159/000051252 · DOI
  26. Ramadori, 2010, SIRT1 deacetylase in POMC neurons is required for homeostatic defenses against diet-induced obesity, Cell Metab., 12, 78, 10.1016/j.cmet.2010.05.010 · DOI
  27. Ramadori, 2008, Brain SIRT1: anatomical distribution and regulation by energy availability, J. Neurosci., 28, 9989, 10.1523/JNEUROSCI.3257-08.2008 · DOI
  28. Sasaki, 2010, Induction of hypothalamic Sirt1 leads to cessation of feeding via agouti-related peptide, Endocrinology, 151, 2556, 10.1210/en.2009-1319 · DOI
  29. Marwarha, 2010, Beta-amyloid regulates leptin expression and tau phosphorylation through the mTORC1 signaling pathway, J. Neurochem., 115, 373, 10.1111/j.1471-4159.2010.06929.x · DOI
  30. Marwarha, 2013, Gadd153 and NF-kappaB crosstalk regulates 27-hydroxycholesterol-induced increase in BACE1 and beta-amyloid production in human neuroblastoma SH-SY5Y cells, PLoS One, 8, e70773, 10.1371/journal.pone.0070773 · DOI
  31. Marwarha, 2011, The oxysterol 27-hydroxycholesterol regulates alpha-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors — relevance to Parkinson's disease, J. Neurochem., 119, 1119, 10.1111/j.1471-4159.2011.07497.x · DOI
  32. Marwarha, 2012, Endoplasmic reticulum stress-induced CHOP activation mediates the down-regulation of leptin in human neuroblastoma SH-SY5Y cells treated with the oxysterol 27-hydroxycholesterol, Cell. Signal., 24, 484, 10.1016/j.cellsig.2011.09.029 · DOI
  33. Grozinger, 2001, Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening, J. Biol. Chem., 276, 38837, 10.1074/jbc.M106779200 · DOI
  34. Mai, 2005, Design, synthesis, and biological evaluation of sirtinol analogues as class III histone/protein deacetylase (sirtuin) inhibitors, J. Med. Chem., 48, 7789, 10.1021/jm050100l · DOI
  35. Kahyo, 2008, A novel chalcone polyphenol inhibits the deacetylase activity of SIRT1 and cell growth in HEK293T cells, J. Pharmacol. Sci., 108, 364, 10.1254/jphs.08203FP · DOI
  36. Jung-Hynes, 2009, Role of sirtuin histone deacetylase SIRT1 in prostate cancer. A target for prostate cancer management via its inhibition?, J. Biol. Chem., 284, 3823, 10.1074/jbc.M807869200 · DOI
  37. Rossner, 2006, Transcriptional and translational regulation of BACE1 expression—implications for Alzheimer's disease, Prog. Neurobiol., 79, 95, 10.1016/j.pneurobio.2006.06.001 · DOI
  38. Baeuerle, 1988, I kappa B: a specific inhibitor of the NF-kappa B transcription factor, Science, 242, 540, 10.1126/science.3140380 · DOI
  39. Baeuerle, 1989, A 65-kappaD subunit of active NF-kappaB is required for inhibition of NF-kappaB by I kappaB, Genes Dev., 3, 1689, 10.1101/gad.3.11.1689 · DOI
  40. Beg, 1993, The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors, Genes Dev., 7, 2064, 10.1101/gad.7.11.2064 · DOI
  41. Chen, 2001, Duration of nuclear NF-kappaB action regulated by reversible acetylation, Science, 293, 1653, 10.1126/science.1062374 · DOI
  42. Gerritsen, 1997, CREB-binding protein/p300 are transcriptional coactivators of p65, Proc. Natl. Acad. Sci. U. S. A., 94, 2927, 10.1073/pnas.94.7.2927 · DOI
  43. Perkins, 1997, Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator, Science, 275, 523, 10.1126/science.275.5299.523 · DOI
  44. Zhong, 1998, Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300, Mol. Cell, 1, 661, 10.1016/S1097-2765(00)80066-0 · DOI · Paper page
  45. Sheppard, 1999, Transcriptional activation by NF-kappaB requires multiple coactivators, Mol. Cell. Biol., 19, 6367, 10.1128/MCB.19.9.6367 · DOI
  46. Vanden, 1999, The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter, J. Biol. Chem., 274, 32091, 10.1074/jbc.274.45.32091 · DOI
  47. Ashburner, 2001, The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression, Mol. Cell. Biol., 21, 7065, 10.1128/MCB.21.20.7065-7077.2001 · DOI
  48. Chen, 2002, Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB, EMBO J., 21, 6539, 10.1093/emboj/cdf660 · DOI · Paper page
  49. Zhong, 2002, The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1, Mol. Cell, 9, 625, 10.1016/S1097-2765(02)00477-X · DOI
  50. Sasaki, 2014, Hypothalamic SIRT1 prevents age-associated weight gain by improving leptin sensitivity in mice, Diabetologia, 57, 819, 10.1007/s00125-013-3140-5 · DOI
  51. Minokoshi, 2004, AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus, Nature, 428, 569, 10.1038/nature02440 · DOI · Paper page
  52. Ceddia, 2005, Direct metabolic regulation in skeletal muscle and fat tissue by leptin: implications for glucose and fatty acids homeostasis, Int. J. Obes. (Lond.), 29, 1175, 10.1038/sj.ijo.0803025 · DOI
  53. Greco, 2009, Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells, Biochem. Biophys. Res. Commun., 380, 98, 10.1016/j.bbrc.2009.01.041 · DOI
  54. Greco, 2011, Leptin boosts cellular metabolism by activating AMPK and the sirtuins to reduce tau phosphorylation and beta-amyloid in neurons, Biochem. Biophys. Res. Commun., 414, 170, 10.1016/j.bbrc.2011.09.050 · DOI
  55. Canto, 2009, PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure, Curr. Opin. Lipidol., 20, 98, 10.1097/MOL.0b013e328328d0a4 · DOI · Paper page
  56. Fulco, 2008, Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt, Dev. Cell, 14, 661, 10.1016/j.devcel.2008.02.004 · DOI
  57. Ruderman, 2010, AMPK and SIRT1: a long-standing partnership?, Am. J. Physiol. Endocrinol. Metab., 298, E751, 10.1152/ajpendo.00745.2009 · DOI · Paper page
  58. Brooks, 2009, How does SIRT1 affect metabolism, senescence and cancer?, Nat. Rev. Cancer, 9, 123, 10.1038/nrc2562 · DOI
  59. Guarente, 2011, Epstein lecture: sirtuins, aging, and medicine, N. Engl. J. Med., 364, 2235, 10.1056/NEJMra1100831 · DOI · Paper page
  60. Lange-Dohna, 2003, Cloning and expression of the rat BACE1 promoter, J. Neurosci. Res., 73, 73, 10.1002/jnr.10639 · DOI
  61. Sastre, 2006, Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma, Proc. Natl. Acad. Sci. U. S. A., 103, 443, 10.1073/pnas.0503839103 · DOI · Paper page
  62. Katsouri, 2011, PPARgamma co-activator-1alpha (PGC-1alpha) reduces amyloid-beta generation through a PPARgamma-dependent mechanism, J. Alzheimers Dis., 25, 151, 10.3233/JAD-2011-101356 · DOI
  63. Kakuma, 2000, Role of leptin in peroxisome proliferator-activated receptor gamma coactivator-1 expression, Endocrinology, 141, 4576, 10.1210/endo.141.12.7804 · DOI

Cited by

Sorted by citations

Metadata

Authors
Marwarha, G., Raza, S., Meiers, C., & Ghribi, O.
Venue
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Publisher
Elsevier BV
Published
2014-09
Volume
1842
Issue
9
Pages
1587-1595
ISSN
0925-4439
DOI
10.1016/j.bbadis.2014.05.015
PMC
PMC4125440
Cited by
107
References
12
Language
en
Status
Retracted
Update notices
Licence
Funders
  • National Institute of Environmental Health Sciences (R01ES014826)
  • National Institutes of Health

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review